Long-Acting Injectable PrEP Therapy for HIV
Types of patients who will likely benefit from long-acting injectable PrEP therapies in the HIV treatment pipeline.
Developments in HIV Prophylaxis: New PrEP Options
An overview of HIV PrEP therapies in the pipeline and their potential roles as they are introduced into the community for use among high-risk populations.
Preventive Health Guidelines and Payer Support for HIV PrEP
Updates to the US Preventive Services Task Force grade A recommendation for HIV PrEP therapy and payer response to supporting providers and pharmacists who prescribe therapies used as prophylaxis.
Patient Adherence to HIV PrEP
Discussion regarding HIV PrEP walkaway rates and strategies that can help support patients and increase adherence to therapy.
Population Health and HIV PrEP
Payer perspective regarding strategies that can be deployed to help improve the patient/provider experience and utilization of PrEP therapy as prophylaxis against HIV.
2 Clarke Drive Cranbury, NJ 08512